{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-022506","form_type":"8-K","ticker":"TELO","cik":"0001971532","company_name":"Telomir Pharmaceuticals, Inc.","filed_at":"2025-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.726337+00:00","generated_at":"2026-05-17T18:29:20.096108+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Telomir Pharmaceuticals Announces In Vitro Data Showing Telomir-1 Inhibits Key Epigenetic Enzymes","bullets":["Telomir-1 inhibited JMJD3, FBXL10, and FBXL11 histone demethylase enzymes in a Eurofins Discovery study.","Overactivation of these enzymes silences tumor suppressors and activates pro-inflammatory and metabolic genes.","Telomir-1 may restore normal gene expression, supporting development in cancer, autoimmune, neurodegeneration, and metabolic disorders.","Data builds on prior results showing Telomir-1 reversed epigenetic silencing of STAT1 and TMS1 in PC3 prostate cancer xenograft models.","Company is preparing to advance Telomir-1 into IND-enabling studies."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-022506","json":"https://secwatch.observer/filing/0001641172-25-022506.json","markdown":"https://secwatch.observer/filing/0001641172-25-022506.md","text":"https://secwatch.observer/filing/0001641172-25-022506.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1971532/000164117225022506/0001641172-25-022506-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1971532/000164117225022506/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-17T18:29:20.096108+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}